Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Zealand Pharma A/S
F:22Z
Zealand Pharma A/S
F:22Z
Price:
30.11
EUR
-2.05%
Market Closed
Market Cap:
€2.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Z
|
Zealand Pharma A/S
F:22Z
|
DK |
|
Frontier Developments PLC
LSE:FDEV
|
UK |
|
Panasonic Holdings Corp
F:MAT
|
JP |
|
L
|
Leifheit AG
F:LEI
|
DE |
|
C
|
Coles Group Ltd
F:2OF
|
AU |
|
KH Group Oyj
F:WE3
|
FI |
|
Happy Belly Food Group Inc
F:W3J
|
CA |
|
FBD Holdings PLC
F:EG7
|
IE |
|
A
|
Astra Agro Lestari Tbk PT
XMUN:ASX
|
ID |
|
C
|
Continental AG
DUS:CON
|
DE |
|
N
|
Nice Call PCL
SET:NCP
|
TH |
Wall St Price Targets
22Z Price Forecast
Based on 18 analysts
Based on 18 analysts
+99% Upside
from
€30.11
today
Zealand Pharma A/S (22Z)’s 12-month stock price forecast through October 2027 has a consensus target of €59.77, implying 99% upside. The forecast is based on price targets from 18 Wall Street analysts.
22Z Analyst Rating
No ratings yet
No ratings yet
Zealand Pharma A/S Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 22Z's stock price target?
Price Target
59.77
EUR
59.77
EUR
According to Wall Street analysts, the average 1-year price target for 22Z is 59.77 EUR with a low forecast of 41.78 EUR and a high forecast of 108.58 EUR.
What is the Revenue forecast for Zealand Pharma A/S?
Projected CAGR
-7%
-7%
Over the last 13 years, the compound annual growth rate for Revenue has been 33%. The projected CAGR for the next 8 years is -7%.
What is the Gross Profit forecast for Zealand Pharma A/S?
Projected CAGR
-64%
-64%
The compound annual growth rate for Gross Profit over the next 3 years is -64%.
What is the Operating Income forecast for Zealand Pharma A/S?
Projected CAGR
-18%
-18%
Over the last 13 years, the compound annual growth rate for Operating Income has been 51%. The projected CAGR for the next 8 years is -18%.